123 related articles for article (PubMed ID: 32913973)
1. Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable Phenotype.
Kardos J; Wobker SE; Woods ME; Nielsen ME; Smith AB; Wallen EM; Pruthi RS; Hayward MC; McGinty KA; Grilley-Olson JE; Patel NM; Weck KE; Black P; Parker JS; Milowsky MI; Hayes DN; Kim WY
JCO Precis Oncol; 2017; 1():. PubMed ID: 32913973
[TBL] [Abstract][Full Text] [Related]
2. Urachal carcinoma: The journey so far and the road ahead.
Kumar R; Harilal S; Abdelgawad MA; Ghoneim MM; Kumar A; Mathew B
Pathol Res Pract; 2023 Mar; 243():154379. PubMed ID: 36821941
[TBL] [Abstract][Full Text] [Related]
3. Molecular Genetic Features of Primary Nonurachal Enteric-type Adenocarcinoma, Urachal Adenocarcinoma, Mucinous Adenocarcinoma, and Intestinal Metaplasia/Adenoma: Review of the Literature and Next-generation Sequencing Study.
Pires-Luis AS; Martinek P; Alaghehbandan R; Trpkov K; Comperat EM; Perez Montiel DM; Bulimbasic S; Lobo J; Henrique R; Vanecek T; Pivovarcikova K; Michalova K; Pitra T; Hora M; Marques A; Lopes JM; Rogala J; Mareckova J; Michal M; Hes O
Adv Anat Pathol; 2020 Sep; 27(5):303-310. PubMed ID: 32520749
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.
Reis H; van der Vos KE; Niedworok C; Herold T; Módos O; Szendrői A; Hager T; Ingenwerth M; Vis DJ; Behrendt MA; de Jong J; van der Heijden MS; Peyronnet B; Mathieu R; Wiesweg M; Ablat J; Okon K; Tolkach Y; Keresztes D; Nagy N; Bremmer F; Gaisa NT; Chlosta P; Kriegsmann J; Kovalszky I; Timar J; Kristiansen G; Radzun HJ; Knüchel R; Schuler M; Black PC; Rübben H; Hadaschik BA; Schmid KW; van Rhijn BWG; Nyirády P; Szarvas T
Int J Cancer; 2018 Oct; 143(7):1764-1773. PubMed ID: 29672836
[TBL] [Abstract][Full Text] [Related]
5. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder.
Wright JL; Porter MP; Li CI; Lange PH; Lin DW
Cancer; 2006 Aug; 107(4):721-8. PubMed ID: 16826584
[TBL] [Abstract][Full Text] [Related]
6. [Urachal cancer - current concepts of a rare cancer (German version)].
Reis H; Szarvas T
Pathologe; 2018 Dec; 39(Suppl 2):291-300. PubMed ID: 30470871
[TBL] [Abstract][Full Text] [Related]
7. Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer.
Thiem S; Herold T; Krafft U; Bremmer F; Tolkach Y; Szász AM; Kriegsmann J; Gaisa NT; Niedworok C; Szarvas T; Reis H
Pathol Int; 2017 Dec; 67(12):597-601. PubMed ID: 29047227
[TBL] [Abstract][Full Text] [Related]
8. [Urachal Cancer: an update of current molecular findings].
Reis H; Mairinger F; Ting S; Nagy N; Witzke KE; Kohl M; Sitek B; Niedworok C; Hadaschik B; Nyirády P; Szarvas T
Pathologe; 2019 Dec; 40(Suppl 3):239-243. PubMed ID: 31705235
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.
Paner GP; McKenney JK; Barkan GA; Yao JL; Frankel WL; Sebo TJ; Shen SS; Jimenez RE
Am J Surg Pathol; 2011 Jun; 35(6):787-98. PubMed ID: 21572312
[TBL] [Abstract][Full Text] [Related]
10. Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.
Paner GP; Lopez-Beltran A; Sirohi D; Amin MB
Adv Anat Pathol; 2016 Mar; 23(2):71-83. PubMed ID: 26849813
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
[TBL] [Abstract][Full Text] [Related]
12. The different morphologies of urachal adenocarcinoma do not discriminate genomically by micro-RNA expression profiling.
Bissonnette ML; Kocherginsky M; Tretiakova M; Jimenez RE; Barkan GA; Mehta V; Sirintrapun SJ; Steinberg GD; White KP; Stricker T; Paner GP
Hum Pathol; 2013 Aug; 44(8):1605-11. PubMed ID: 23528864
[TBL] [Abstract][Full Text] [Related]
13. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.
Gopalan A; Sharp DS; Fine SW; Tickoo SK; Herr HW; Reuter VE; Olgac S
Am J Surg Pathol; 2009 May; 33(5):659-68. PubMed ID: 19252435
[TBL] [Abstract][Full Text] [Related]
14. Urachal cancer-current concepts of a rare cancer.
Reis H; Szarvas T
Pathologe; 2019 Jun; 40(Suppl 1):31-39. PubMed ID: 30895340
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.
Johnson A; Severson E; Gay L; Vergilio JA; Elvin J; Suh J; Daniel S; Covert M; Frampton GM; Hsu S; Lesser GJ; Stogner-Underwood K; Mott RT; Rush SZ; Stanke JJ; Dahiya S; Sun J; Reddy P; Chalmers ZR; Erlich R; Chudnovsky Y; Fabrizio D; Schrock AB; Ali S; Miller V; Stephens PJ; Ross J; Crawford JR; Ramkissoon SH
Oncologist; 2017 Dec; 22(12):1478-1490. PubMed ID: 28912153
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Korean patients with clinically localized urachal or non-urachal adenocarcinoma of the bladder.
Cho SY; Moon KC; Park JH; Kwak C; Kim HH; Ku JH
Urol Oncol; 2013 Jan; 31(1):24-31. PubMed ID: 21458312
[TBL] [Abstract][Full Text] [Related]
17. Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors.
Salem ME; Bodor JN; Puccini A; Xiu J; Goldberg RM; Grothey A; Korn WM; Shields AF; Worrilow WM; Kim ES; Lenz HJ; Marshall JL; Hall MJ
Int J Cancer; 2020 Nov; 147(10):2948-2956. PubMed ID: 32449172
[TBL] [Abstract][Full Text] [Related]
18. Urachal cancer: contemporary review of the pathological, surgical, and prognostic aspects of this rare disease.
Behrendt MA; DE Jong J; VAN Rhijn BW
Minerva Urol Nefrol; 2016 Apr; 68(2):172-84. PubMed ID: 26583595
[TBL] [Abstract][Full Text] [Related]
19. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
[TBL] [Abstract][Full Text] [Related]
20. Mutational Profile Using Next-Generation Sequencing May Aid in the Diagnosis and Treatment of Urachal Adenocarcinoma.
Cornejo KM; Cosar EF; Paner GP; Yang P; Tomaszewicz K; Meng X; Mehta V; Sirintrapun SJ; Barkan GA; Hutchinson L
Int J Surg Pathol; 2020 Feb; 28(1):51-59. PubMed ID: 31496327
[No Abstract] [Full Text] [Related]
[Next] [New Search]
